ADMA
ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
ADMA fundamentals
ADMA Biologics (ADMA) Revenue Breakdown: Q3 2025 Business & Regional Performance
ADMA Biologics (ADMA) reported total revenue of 134.22M USD in Q3 2025, with its core business segment ADMA Biomanufacturing contributing 99.97%. Regionally, United States remained the largest market, accounting for 99.82% of total revenue. Explore ADMA Biologics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
ADMA Biologics (ADMA) reported total revenue of 134.22M USD in Q3 2025, with its core business segment ADMA Biomanufacturing contributing 99.97%. Regionally, United States remained the largest market, accounting for 99.82% of total revenue. Explore ADMA Biologics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in ADMA Biologics's revenue and profit?Did ADMA Biologics beat or miss consensus estimates last quarter?What does ADMA Biologics do and what are its main business segments?What is the market's earnings forecast for ADMA Biologics next quarter?What is ADMA Biologics's latest dividend and current dividend yield?What guidance did ADMA Biologics's management provide for the next earnings period?What is the revenue and EPS growth rate for ADMA Biologics year over year?What is ADMA Biologics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
